Tokushima Red Cross Hospital, Department of Cardiology, Tokushima, Japan.
Tokushima Red Cross Hospital, Department of Cardiology, Tokushima, Japan.
Cardiovasc Revasc Med. 2021 Apr;25:44-46. doi: 10.1016/j.carrev.2020.10.013. Epub 2020 Oct 29.
It has been reported that successful percutaneous coronary intervention for chronic total occlusion (CTO-PCI) might be associated with symptom relief, a lower rate of subsequent myocardial infarction and coronary artery bypass graft surgery, and improved long-term survival, compared with unsuccessful PCI for CTO. However, the long-term benefit of percutaneous recanalization of CTO remains unclear. Therefore, we aimed to evaluate the long-term benefit of percutaneous recanalization of CTO.
We analyzed consecutive cases of CTO-PCI performed between January 2000 and December 2006. The health status of all patients on September 2017 was obtained via letter or from medical records. We collected relevant patient information as well as angiographic and procedural characteristics.
A total of 477 patients (82.8% men, mean age, 65.7 years) underwent CTO-PCI. The procedural was successful in 382 cases (80.3%). Reference vessel diameter, occlusion length and angiographic stump of CTO site were associated with the success of CTO intervention. During the mean follow-up period of 139.8 months, successful CTO-PCI was associated with a higher survival rate when compared with failed CTO-PCI (Log-rank test: P = 0.0147). When categorized by target vessel, successful revascularization of left anterior descending (LAD) -CTO improved long-term survival (Log-rank test: P = 0.0041). On the other hand, successful revascularization of right coronary artery or left circumflex -CTO was not associated with improved long-term survival [Log-rank test: P = 0.5631 (RCA), P = 0.2774 (LCX)].
Successful CTO-PCI, especially the successful revascularization of LAD-CTO, improved long-term survival of patients.
据报道,慢性完全闭塞(CTO-PCI)经皮冠状动脉介入治疗的成功与症状缓解、后续心肌梗死和冠状动脉旁路移植术发生率降低以及长期生存率提高相关,与 CTO-PCI 不成功相比。然而,CTO 经皮再通的长期获益仍不清楚。因此,我们旨在评估 CTO 经皮再通的长期获益。
我们分析了 2000 年 1 月至 2006 年 12 月间连续进行的 CTO-PCI 病例。于 2017 年 9 月通过信函或病历获取所有患者的健康状况。我们收集了相关患者信息以及血管造影和手术特征。
共 477 例患者(82.8%为男性,平均年龄 65.7 岁)接受了 CTO-PCI。382 例(80.3%)手术成功。参考血管直径、闭塞长度和 CTO 部位的血管造影残端与 CTO 干预的成功相关。在平均 139.8 个月的随访期间,与 CTO-PCI 不成功相比,成功的 CTO-PCI 与更高的生存率相关(Log-rank 检验:P=0.0147)。按靶血管分类,左前降支(LAD)-CTO 的血运重建成功改善了长期生存率(Log-rank 检验:P=0.0041)。另一方面,右冠状动脉或左回旋支-CTO 的血运重建成功与长期生存率的改善无关[Log-rank 检验:P=0.5631(RCA),P=0.2774(LCX)]。
成功的 CTO-PCI,特别是 LAD-CTO 的血运重建,改善了患者的长期生存率。